Rare diseases
Investigational molecules
Locations
Back to Spain56 clinical trials in Logrono, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainStudy of PC14586 for Patients with Advanced Solid Tumors with a Specific TP53 Mutation
SpainStudy on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors
SpainStudy of ATX-898 alone and in drug combination for patients with advanced solid tumors
SpainPhase 1/2 Study of Oral TRI-611 in Adults With Advanced ALK‑Positive Non‑Small Cell Lung Cancer
SpainSafety and Tolerability of Inhaled KB707 with or without Docetaxel in Patients with Advanced Lung Solid Tumors
SpainDB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors
SpainA study to evaluate the safety and effectiveness of petosemtamab and pembrolizumab in adults with non-small cell lung cancer
SpainA study to evaluate the safety and effectiveness of PTT-4256 and nivolumab in patients with solid tumors.
SpainStudy of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety
SpainStudy on the Effectiveness of N-Acetylcysteine and Methylprednisolone for Patients with Severe Acute Alcoholic Hepatitis
SpainStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on non-muscle invasive bladder cancer treatment, comparing electric current-administered mitomycin C with standard immunotherapy. Research includes evaluation of novel biomarkers for tumor detection.
Advanced therapeutic approaches combining traditional and innovative treatment methods.
Clinical research examining treatment outcomes for severe acute alcoholic hepatitis, investigating the effectiveness of combination therapy using methylprednisolone and N-acetylcysteine.
Focus on improving survival rates in severe cases.
Comprehensive studies on bacterial infections, including Pseudomonas aeruginosa bacteremia and Enterobacteriales infections. Evaluation of optimal antibiotic treatment durations and alternative therapeutic approaches.
Advancing antimicrobial stewardship through evidence-based research.
Breakthrough studies in multiple sclerosis treatment, comparing the efficacy of remibrutinib versus teriflunomide in managing relapsing forms of the disease.
Focused on improving quality of life for MS patients.
Investigation of treatment strategies for acute myocardial infarction, evaluating evolocumab's effectiveness in reducing cardiovascular events and hospitalizations.
Emphasis on real-world clinical outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
